SCHEMBL20765893

SCHEMBL20765893

COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)[C@H]2CCCN(C)C2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.61
HTR2C P28335 5/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C19 P33261 2/20 0.61
KCNH2 Q12809 2/20 0.61
ABCB11 O95342 1/20 0.61
ADRB2 P07550 1/20 0.61
CHRM2 P08172 1/20 0.61
CHRM1 P11229 1/20 0.61
DRD1 P21728 1/20 0.61
TBXA2R P21731 1/20 0.61
SLC6A2 P23975 1/20 0.61
GPR183 P32249 1/20 0.61
ADRA1A P35348 1/20 0.61
OPRM1 P35372 1/20 0.61
APLNR P35414 1/20 0.61
DRD3 P35462 1/20 0.61
CX3CR1 P49238 1/20 0.61
SLC6A3 Q01959 1/20 0.61
GPR65 Q8IYL9 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766039 0.89 HTR2A (0.55) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20794534 0.89 HTR2A (0.48) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20794850 0.89 HTR2A (0.48) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20794669 0.89 HTR2A (0.48) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20765895 0.88 HTR2A (0.80) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20766270 0.88 HTR2A (0.80) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL3961952 0.88 HTR2A (0.77) HTR2AHTR2CCYP1A2CYP2C19KCNH2
SCHEMBL20765854 0.85 HTR2A (0.51) HTR2AOPRM1
SCHEMBL20766115 0.85 HTR2A (0.51) HTR2AOPRM1
SCHEMBL20794846 0.85 HTR2A (0.51) HTR2AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040106-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed
WO-2019040106-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed
WO-2019040106-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed